Table 2.
Group | Genotype/subtype | Infectivity (%) | |||
---|---|---|---|---|---|
Acute infectiona | Chronic infectiona | Inapparent infectiona | No sign of infection | ||
A | hHEV-3b | 0/5 (0) | 0/5 (0) | 3/5 (60) | 2/5 (40) |
B | hHEV-4d | 5/5 (100) | 0/5 (0) | 0/5 (0) | 0/5 (0) |
C | sHEV-4d | 4/5 (80) | 0/5 (0) | 0/5 (0) | 1/5 (20) |
D | sHEV-4h | 0/5 (0) | 0/5 (0) | 0/5 (0) | 5/5 (100) |
E | HEV8 | 0/5 (0) | 0/5 (0) | 1/5 (20) | 4/5 (80) |
F | HEV-3ra | 4/5 (80) | 1/5 (20) | 0/5 (0) | 0/5 (0) |
G | hHEV-4a | 0/2 (0) | 0/2 (0) | 0/2 (0) | 2/2 (100) |
H | hHEV-4h | 0/2 (0) | 0/2 (0) | 0/2 (0) | 2/2 (100) |
I | Negative control | 0/3 (0) | 0/3 (0) | 0/3 (0) | 3/3 (100) |
NA, not applicable; NT, not tested.
Acute infection: fecal virus shedding less than 3 months; chronic infection: fecal virus shedding over 3 months; inapparent infection: no signs of HEV infection except for seroconversion to anti-HEV antibody.